尤瑞克林对不同亚型急性脑梗死效果探讨.docVIP

尤瑞克林对不同亚型急性脑梗死效果探讨 　　[摘要] 目的 研究分析尤瑞克林对不同亚型急性脑梗死的临床效果。方法 方便选取该院于2014年3月―2015年2月收治90例急性脑梗死患者应用OCSP分型分为对照组和观察组，对照组有40例，观察组急性脑梗死患者有50例，同时对照组中的急性脑梗死患者进行丹参治疗，观察组中的急性脑梗死患者在对照组基础上应用尤瑞克林针进行治疗，对两组患者临床效果进行比较。 结果 ①两组患者治疗后神经功能缺损程度评分低于对照组，P0.05，差异有统计学意义；②观察组患者临床有效率（80%）和对照组（60%）比较，观察组较高，P0.05，差异有统计学意义。结论 尤瑞克林不仅仅可以对急性脑梗死患者神经功能缺损评分进行改善，同时也有着安全用药特点，临床疗效较高。 　　[关键词] 尤瑞克林；进行脑梗死；不同亚型；疗效 　　[中图分类号] R5 [文献标识码] A [文章编号] 1674-0742（2016）09（c）-0126-03 　　[Abstract] Objective Observation on the effect analysis of Urinary Kauidinogenase in different subtypes of acute cerebral infarction. Methods Convenient selection our hospital in March 2014 to February 2015 were 90 cases of acute cerebral infarction patients with OCSP type is divided into the observation group and the control group， 40 cases in the control group， 50 patients with acute cerebral infarction group was observed， while the control group of patients with acute cerebral infarction were treated with Salvia miltiorrhiza， observation group in acute cerebral infarction patients in the control group on the basis of the application of urinary kallidinogenase needle treatment， to compare the clinical effect of two groups of patients.Results ①after treatment， the patients in the two groups of nerve function defect score lower than control group， P 0.05， indicating statistically significant；② were observed in the group of patients with clinical efficiency （80%） and control group （60%） in comparison， observation group was higher， P 0.05， the difference was statistical significance. Conclusion Urinary Kauidinogenase not only can improve the neurological function defect score of patients with acute cerebral infarction， but also has the characteristics of safe medication， the clinical curative effect is high. 　　[Key words] Urinary Kauidinogenase； Cerebral infarction； Different subtypes； Therapeutic effect 　　近些年来，急性脑梗死有着较高的发病率，同时也有着较高的复发率，临床医学多采用阿替普酶进行治疗，但是疗效不显著[1]。脑梗死依据发病机制的不同分为脑血栓形成、脑栓塞和腔隙性脑梗死等主要类型。其中脑血栓形成是脑梗死最常见的类型，约占全部脑梗死的60%[2]。该院在201